AN
43
-6
AME
66
4
ADT
48
-2
AMP
66
-3
CINF
66
2
D
45
-3
EXR
24
-4
ABBV
46
-4
AEP
64
5
DHR
64
2
ADSK
62
6
DHI
41
9
CMA
65
-6
ACN
52
-4
AMZN
52
4
AEE
58
3
CMCSA
46
-10
ADI
72
2
VIX
32
-12
AON
67
2
AN
43
-6
AME
66
4
ADT
48
-2
AMP
66
-3
CINF
66
2
D
45
-3
EXR
24
-4
ABBV
46
-4
AEP
64
5
DHR
64
2
ADSK
62
6
DHI
41
9
CMA
65
-6
ACN
52
-4
AMZN
52
4
AEE
58
3
CMCSA
46
-10
ADI
72
2
VIX
32
-12
AON
67
2
Financhill
Back

Vanguard Short-Term Tax-Exempt Bond ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
43

VTES
Vanguard Short-Term Tax-Exempt Bond ETF

Last Price:
$101.58
Seasonality Move:
1.31%
Sell
44

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.76
Seasonality Move:
-13.08%
Sell
43
Vanguard Short-Term Tax-Exempt Bond ETF (VTES) is a Sell

Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.58. The Score for VTES is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • VTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTES Stock Price Chart

What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?

  • The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

VTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.36 Buy
Relative Strength Index (14 RSI): 54.87 Buy
Chaikin Money Flow: -64248 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.42 - 101.58) Buy
Bollinger Bands (100): (101.41 - 101.89) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.8 Buy
Relative Strength Index (14 RSI): 56.8 Buy
Chaikin Money Flow: 32783 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 111.03) Buy
Bollinger Bands (100): (95.29 - 108.53) Buy

VTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.52 Buy
20-day SMA: 101.51 Buy
50-day SMA: 101.55 Buy
200-day SMA: 101.03 Buy
8-day EMA: 40.13 Buy
20-day EMA: 18.43 Buy
50-day EMA: 7.81 Buy
200-day EMA: 2.01 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.65 Buy
20-day SMA: 107.3 Buy
50-day SMA: 106.17 Buy
200-day SMA: 82.91 Buy
8-day EMA: 44.16 Buy
20-day EMA: 20.28 Buy
50-day EMA: 8.6 Buy
200-day EMA: 2.21 Buy

Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):